Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Grail’s cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation ...

A single blood draw that can detect 50 different types of cancer sounds like science fiction, but it's already available to ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...

While the test involves taking blood, Katherine was floored to find out she had been billed £6,000 for the test. "I got an email right after my meeting with the oncologist from the patient ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis of Alzheimer's disease. The immunoassay measures the ratio of ptau-217 and beta amyloid 42, two distinct ...

He has started prescribing a new kind of screening — the Shield blood test — for his patients who are hesitant to get a colonoscopy. For a decade, we've had stool collection kits like Cologuard.

Image Credit: vectorfusionart / Shutterstock Can one blood test someday inform personalized asthma treatment? Millions live with asthma, yet the symptoms vary significantly from person to person ...

Katherine Ryan has revealed she was hit with a surprise £6,000 bill for a blood test offered as part of her follow-up care after being treated for skin cancer. The 41-year-old comedian recently ...

Video game-based tests for early Alzheimer's detection may be as effective as blood tests, offering a noninvasive, cost-effective alternative that doesn't require blood samples or trained technicians.